Pmv Pharmaceuticals, Inc. · NASDAQ:PMVP
Srinivas Akkaraju reported a 9.90% stake in Pmv Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 2, 2026 · Filed Sep 15, 2026
Srinivas Akkaraju reported a 9.90% stake in Pmv Pharmaceuticals, Inc., 7,577,467 shares, as a passive investor on Sep 2, 2026. Filed Sep 15, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 7,577,467
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Samsara BioCapital, L.P. | 5.00% | 3,788,734 |
| Samsara BioCapital GP, LLC | 5.00% | 3,788,734 |
| Samsara Opportunity Fund, L.P. | 5.00% | 3,788,733 |
| Samsara Opportunity Fund GP, LLC | 5.00% | 3,788,733 |
| Srinivas Akkaraju | 9.90% | 7,577,467 |
Source
Related
- Pmv Pharmaceuticals, Inc.
- Srinivas Akkaraju
- Pmv Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Sio Capital Management, LLC · Jul 28, 2026
- Schedule 13G/A · ArrowMark Colorado Holdings LLC · Jul 10, 2026
- Schedule 13G/A · Euclidean Capital LLC · May 15, 2026
- Schedule 13G/A · Sio Capital Management, LLC · May 4, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Mar 4, 2026